Cyberonics reneged on its "Lifetime Reimbursement Guarantee". Click on the image to learn how you can help...
Showing posts with label treatment resistant depression. Show all posts
Showing posts with label treatment resistant depression. Show all posts

Tuesday, September 30, 2014

Transcranial Magnetic Stimulation Offers Hope for Treatment-Resistant Depression

Therese Borchard
Sanity Break

Help for depression and anxiety

 

Transcranial Magnetic Stimulation Offers Hope for Treatment-Resistant Depression

By Therese Borchard

Published Sep 29, 2014

In December of 2012, Stephanie S. was taking 300 mgs of sertraline (Zoloft), 300 mgs of (bupropion Hcl) Wellbutrin, 300 mgs of trazodone hydrochloride (Desyrel), 200 mgs of risperidone (Risperdal), and 8 mgs of alprazolam (Xanax), but was as depressed as she has ever been. She had also gained 100 pounds as a side effect of all the medications. Having tried a total of 10 different kinds of drugs with no success, her doctor recommended transcranial magnetic stimulation (TMS), a non-invasive procedure that stimulates nerve cells in the brain with short magnetic pulses. A large electromagnetic coil is placed against the scalp which generates focused pulses that pass through the skull and stimulate the cerebral cortex of the brain, a region that regulates mood. The procedure was approved by the FDA in 2008.

She didn’t feel any difference after 11 treatments, but she can vividly remember the morning after her 12th treatment. She explained:

I woke up… I mean WOKE UP!! I felt so light, instead of feeling weighed down. The sun was brighter. My overall feeling was JOY. This was unfamiliar to me, and I loved it. I came downstairs grinning from ear to ear and just looked at my husband. He knew! I just threw my arms around his neck and laughed. The feeling was indescribable. It was NIRVANA!! I felt better than I had felt before my breakdown. It was MAGICAL! I think that was the first time in my life that I felt pure joy!

She continued and finished the 30 treatments.

Dr. Kira Stein, MD, board certified psychiatrist and medical director of West Coast TMS Institute in Sherman Oaks, Los Angeles, is excited about the success she’s had in treating her patients with TMS. She usually does five sessions a week, for a total of 30 sessions; the entire procedure lasts about six to eight weeks, though some patients may need more treatment to respond.

She estimates that about one-third of TMS patients have a full remission and no longer experience depression symptoms.

One-half of TMS patients respond signficantly, where their depression symptoms are improved by at least 50 percent, but do not reach complete remission. The more depressive cycles they have had in their lives, the more difficult it is to treat them in general.

Dr. Stein’s experience is that TMS success rates are higher when TMS is used as an augmentation strategy for patients who have only partially responded to medication, or who cannot tolerate higher medication doses. She usually recommends a person stay on a dose of maintenance antidepressants and finds that some patients need maintenance TMS treatments to stay well.

The treatment is expensive. Dr. Stein says that each session (and on average people usually require 30) run from $300 to $450, a session; however, more and more insurance companies are picking up at least some of the bill.

Stephanie paid $7,450 out of pocket. Her insurance chipped in $7,000 (the total cost was about $14,000).

Stephanie stayed in remission for a year and a half until a cascade of tragic events, including the suicide of her sister, caused a relapse of depressive symptoms. When different kinds of medication again did little to relieve her pain, she decided to do TMS for a second time.

She’s been participating in the online depression support group I moderate on Facebook. About a month ago, I remember a distinct change in the tone of her posts. They went from being desperate to hopeful, from cynical to curious, and from flat to playful.

“What’s the matter with me?” she asked the group. “On the way to my husband’s work, I’m noticing everything for the first time.”

“I think your TMS treatment is working,” I replied.

“Yes!” she said. “I laughed again!!”

She has eight treatments left, and hopes she continues to laugh for a very long time.

Posted in: Depression

6 Comments

http://www.everydayhealth.com/columns/therese-borchard-sanity-break/transcranial-magnetic-stimulation-tms-offers-hope-for-treatment-resistant-depression/

Wednesday, September 17, 2014

Response to TMS Sustained in Depression

Medscape Medical News > Psychiatry

Response to TMS Sustained in Depression

Pam Harrison

September 17, 2014

 

 

The final analysis of a study evaluating transcranial magnetic stimulation (TMS) confirms that the majority of patients with resistant depression who respond to TMS in the acute setting continue to have a sustained response for a period of 1 year, an observational trial shows.

David Dunner, MD, director, Center for Anxiety and Depression, Mercer Island, Washington, and colleagues reported that 68% of 257 patients who had received TMS during the acute treatment phase had improved by the end of the 12-month follow-up and that 45% had experienced complete remission at 1 year.

"These are patients with treatment-resistant depression who are difficult to treat, who generally do not get better easily. TMS not only got people better with the usual course of about 30 treatments in the acute treatment phase, but we showed that the benefit was maintained over a 1-year period in the majority of patients who improved," Dr. Dunner told Medscape Medical News.

Courtesy of Neuronetics, Inc.

"So I view TMS as a treatment for people who have a new depression and who have a history of failing 3 or 4 prior treatments for depression, where it is unlikely that the antidepressant is going to work. In that population, I think we get good results, and the results justify the use of TMS and the cost of treatment as well."

The final results of the observational study were published online on September 16 in the Journal of Clinical Psychiatry. Preliminary long-term results were first reported from the American Psychiatric Association meeting in 2013 by Medscape Medical News. The study was supported by Neuronetics Inc.

Long-term Results

As investigators previously reported ( Depress Anxiety. 2012;29:587-596), 62% of patients had achieved symptomatic improvement, and 41% had achieved a complete remission by the end of the acute treatment phase.

http://www.medscape.com/viewarticle/831860

Tuesday, May 6, 2014

Safe Use of Repetitive Transcranial Magnetic Stimulation in Patients With Implanted Vagus Nerve Stimulators.

Brain Stimul. 2014 Apr 12. pii: S1935-861X(14)00129-6. doi: 10.1016/j.brs.2014.04.001. [Epub ahead of print]

Safe Use of Repetitive Transcranial Magnetic Stimulation in Patients With Implanted Vagus Nerve Stimulators.

Philip NS1, Carpenter SL2, Carpenter LL3.

Author information
  • 1Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, RI, USA; Laboratory for Clinical and Translational Neuroscience, Butler Hospital, USA; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, USA. Electronic address: Noah_Philip@Brown.edu.
  • 2Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, Providence, RI, USA.
  • 3Laboratory for Clinical and Translational Neuroscience, Butler Hospital, USA; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, USA.
Abstract

Vagus nerve stimulation (VNS) and repetitive transcranial stimulation (rTMS) devices are FDA cleared for therapeutic use in treatment resistant depression. Since VNS systems have ferromagnetic components and large-scale safety testing has not been done, the implanted VNS device is considered a contraindication for rTMS therapy. This contraindication should not be considered absolute, as VNS components typically lie outside the electromagnetic field generated by an rTMS treatment coil. We solicited information from clinicians at several academic medical centers through an informal survey about their use of rTMS for depressed patients with implanted VNS systems, and reviewed relevant safety issues with one rTMS device manufacturer. rTMS clinical practices may use special consent procedures and take additional precautions to enhance safety in these situations. Specific recommendations are provided for minimizing risks (heating or movement of VNS components and unintended change in VNS stimulation parameters) when delivering rTMS to patients with implanted VNS systems.

Copyright © 2014 Elsevier Inc. All rights reserved.

KEYWORDS:

Repetitive transcranial magnetic stimulation, Safety, Treatment-resistant depression, Vagus nerve stimulation

PMID:
24794163
[PubMed - as supplied by publisher]
Related citations in PubMed

See reviews...See all...
http://www.ncbi.nlm.nih.gov/pubmed/24794163